Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
2 Apr 2026 Job Information Organisation/Company CNRS Department Institut Fresnel Research Field Engineering Physics Technology Researcher Profile First Stage Researcher (R1) Application Deadline 22
-
excellence in education, patient care, community service, research and technology development, and through leadership activities in Michigan, nationally and internationally. Our mission is guided by our
-
, Orthopaedics, Regenerative Medicine, or a related discipline. Demonstrated research experience in tissue engineering, regeneration, biomaterials, hydrogel systems, 3D bioprinting, implantable devices, or related
-
the development and deployment of quantitative pathology. Leveraging our network of expert pathologists and the department?s extensive basic sciences knowledgebase, the DCPL aims to advance tissue-based diagnostics
-
2 Apr 2026 Job Information Organisation/Company CNRS Department Institut d'Electronique de Microélectronique et de Nanotechnologie Research Field Engineering Physics Technology Researcher Profile
-
14 Mar 2026 Job Information Organisation/Company Politecnico di Torino Research Field Engineering Chemistry Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage
-
Summary Histotechnologist I Perform complex activities in the preparation of tissue for microscopic examination for the Dermatopathology Laboratory. Place tissues in fixative solution to stabilize and
-
Deciphering Streptococcus dysgalactiae subsp. equisimilis Population Genomics and Host-Pathogen Interactions using Advanced 3D Tissue Engineered Infection Models School of Biosciences PhD Research
-
systems at homeostasis and under pathological conditions. More information on the lab can be found on our website: https://www.littmanlab.org We are looking for someone with a strong background in the
-
the functional diversification of synapses in defined neural circuits. In this project, you will use an array of approaches, including CRISPR/Cas9 genome editing, viral vector technology, and quantitative super